↓ Skip to main content

Dove Medical Press

Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
10 X users
reddit
1 Redditor

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
8 Mendeley
Title
Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study
Published in
Therapeutics and Clinical Risk Management, November 2021
DOI 10.2147/tcrm.s332218
Pubmed ID
Authors

Weisheng Chen, Mengjing Wang, Minmin Zhang, Weichen Zhang, Jun Shi, Jiamin Weng, Bihong Huang, Kamyar Kalantar-Zadeh, Jing Chen

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 25%
Student > Ph. D. Student 1 13%
Student > Bachelor 1 13%
Student > Doctoral Student 1 13%
Unknown 3 38%
Readers by discipline Count As %
Business, Management and Accounting 1 13%
Nursing and Health Professions 1 13%
Agricultural and Biological Sciences 1 13%
Social Sciences 1 13%
Medicine and Dentistry 1 13%
Other 0 0%
Unknown 3 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2022.
All research outputs
#6,759,465
of 25,392,582 outputs
Outputs from Therapeutics and Clinical Risk Management
#326
of 1,323 outputs
Outputs of similar age
#127,827
of 443,559 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 13 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,559 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.